A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Completed · Phase 2

Conditions studied: Glaucoma, Ocular Hypertension (OH)

In brief

The purpose of this study is to evaluate the efficacy, safety and duration of the L-PPDS (latanoprost punctal plug delivery system) at different dose levels.

Key facts

Study ID

NCT01481051

Run by

Mati Therapeutics Inc.

People needed

57

Starts

2011-11-01

Expected to finish

2012-09-01

Last updated by the study team

2013-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female at least 18 years old
• Diagnosis of bilateral open angle glaucoma or ocular hypertension
• Unmedicated IOP must be ≥22mm Hg

You may not qualify if…

• Any significant vision loss in the last year
• No contact lens use for the length of the study
• Abnormal eye lids, eye infection, or diseases to the eye
• Recent eye surgery
• Uncontrolled medication conditions

Where it is running

• Sall Research Medical Center, Inc — Artesia, California, United States
• Wolstan & Goldberg Eye Associates — Los Angeles, California, United States
• West Coast Eye Care Associates — San Diego, California, United States
• Coastal Research Associates, LLC — Roswell, Georgia, United States
• R and R Eye Associates — San Antonio, Texas, United States
• Rocky Mountain Eye Care Associates — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.